↓ Skip to main content

Immune Modulation Therapy and Imaging: Workshop Report

Overview of attention for article published in Journal of Nuclear Medicine, August 2017

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
guideline
1 clinical guideline source

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Immune Modulation Therapy and Imaging: Workshop Report
Published in
Journal of Nuclear Medicine, August 2017
DOI 10.2967/jnumed.117.195610
Pubmed ID
Authors
Abstract

A workshop at the National Cancer Institute May 2, 2016 considered the current state of imaging in assessment of immunotherapy. Immunotherapy has shown some remarkable and prolonged responses in the treatment of tumors. However, responses are variable and frequently delayed, complicating the evaluation of new immunotherapy agents and customizing treatment for individual patients. Early anatomic imaging may show that a tumor has increased in size, but this could represent pseudoprogression. Based on imaging, clinicians must decide if they should stop, pause, or continue treatment. Other imaging technologies and approaches are being developed to improve the measurement of response in patients receiving immunotherapy. Imaging methods being evaluated include radiomic methods using computed tomography (CT), magnetic resonance imaging (MRI) and (18)F-FDG-PET (fluorodeoxyglucose-positron emission tomography) as well as new radiolabeled small molecules, antibodies, and antibody fragments to image the tumor microenvironment, immune status and changes over the course of therapy. Current studies of immunotherapy can take advantage of these available imaging options to explore and validate their use. Collection of CT, PET, and MR images along with outcomes from trials are critical to develop improved methods of assessment.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 7 21%
Student > Ph. D. Student 5 15%
Other 3 9%
Student > Bachelor 3 9%
Student > Master 2 6%
Other 4 12%
Unknown 9 27%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 11 33%
Immunology and Microbiology 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Mathematics 1 3%
Other 5 15%
Unknown 10 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2018.
All research outputs
#11,219,100
of 33,087,078 outputs
Outputs from Journal of Nuclear Medicine
#3,930
of 8,013 outputs
Outputs of similar age
#132,674
of 349,183 outputs
Outputs of similar age from Journal of Nuclear Medicine
#49
of 90 outputs
Altmetric has tracked 33,087,078 research outputs across all sources so far. This one has received more attention than most of these and is in the 65th percentile.
So far Altmetric has tracked 8,013 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,183 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.